Equities

Avid Bioservices Inc

Avid Bioservices Inc

Actions
  • Price (EUR)11.50
  • Today's Change0.10 / 0.88%
  • Shares traded6.00
  • 1 Year change+130.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 07:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Apr 30 2024202420232022
ASSETS
Cash And Short Term Investments3839126
Total Receivables, Net292826
Total Inventory304426
Prepaid expenses6.512.091.88
Other current assets, total------
Total current assets104112180
Property, plant & equipment, net228221130
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets4.884.474.63
Total assets337452430
LIABILITIES
Accounts payable21259.50
Accrued expenses6.791011
Notes payable/short-term debt01410
Current portion long-term debt/capital leases1.450.530.51
Other current liabilities, total423954
Total current liabilities7121576
Total long term debt1611.56142
Total debt162143142
Deferred income tax0.07----
Minority interest------
Other liabilities, total444638
Total liabilities276262255
SHAREHOLDERS EQUITY
Common stock0.060.060.06
Additional paid-in capital633620606
Retained earnings (accumulated deficit)(572)(431)(431)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity61189175
Total liabilities & shareholders' equity337452430
Total common shares outstanding646362
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.